The effects of vitamin D therapy on left ventricular structure and function - are these the underlying explanations

Adrian Covic1, Luminita Voroneanu, David Goldsmith

  • 1Nephrology Clinic, Parhon University Hospital, Gr. T. Popa University of Medicine and Pharmacy, Iasi, Romania. lumivoro@yahoo.com

Insights

Vitamin D deficiency is common in chronic kidney disease (CKD) patients. This review explores how vitamin D impacts cardiovascular health and left ventricular hypertrophy (LVH) in CKD patients.

Area of Science:

  • Nephrology
  • Cardiology
  • Endocrinology

Background:

  • Cardiovascular disease (CVD) is a leading cause of mortality in chronic kidney disease (CKD) patients.
  • Vitamin D deficiency is prevalent in CKD, coinciding with frequent left ventricular abnormalities.
  • Left ventricular hypertrophy (LVH) progresses with declining renal function and dialysis initiation.

Purpose of the Study:

  • To review the evidence linking vitamin D to cardiac structure and function in CKD patients.
  • To investigate the potential mechanisms connecting mineral metabolism and LVH.
  • To examine the dual role of vitamin D in cardiovascular outcomes and LVH.

Main Methods:

  • Review of recent observational studies and existing literature.
  • Analysis of factors contributing to LVH in CKD patients.
  • Exploration of vitamin D's association with cardiovascular mortality and LVH.

Main Results:

  • Observational studies suggest vitamin D treatment may reduce cardiovascular death and LVH in dialysis patients.
  • Conversely, excess vitamin D is linked to hypercalcemia, vascular calcification, and reduced survival.
  • The relationship between vitamin D, mineral metabolism, and cardiac morphology requires further elucidation.

Conclusions:

  • Vitamin D's role in CKD cardiovascular health is complex and warrants further investigation.
  • Understanding this link is crucial for managing cardiovascular risk in CKD patients.
  • Further research is needed to clarify optimal vitamin D management strategies for CKD patients.

Related Concept Videos

Chronic Kidney Disease III: Interprofessional Care01:28

Chronic Kidney Disease III: Interprofessional Care

Chronic kidney disease (CKD) requires collaborative and comprehensive management. CKD progresses through stages and can lead to end-stage kidney disease (ESKD) if untreated. Interprofessional collaboration and patient education are crucial, enabling patients to manage their health and improve their quality of life.Diagnostic approach for chronic kidney diseaseThe diagnosis of CKD primarily focuses on the glomerular filtration rate (GFR), which assesses kidney function by measuring how well...
Cardiomyopathy II: Dilated Cardiomyopathy01:30

Cardiomyopathy II: Dilated Cardiomyopathy

Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
Chronic Kidney Disease I: Introduction01:25

Chronic Kidney Disease I: Introduction

Chronic Kidney Disease (CKD) arises when the kidneys progressively lose their ability to function, ultimately leading to end-stage renal disease. At this advanced stage, the kidneys can no longer filter waste or maintain essential body functions, requiring renal replacement therapy (RRT) through dialysis or a kidney transplant for survival.Early-stage chronic kidney disease and detection challengesIn CKD's early stages, symptoms often remain absent because healthy nephrons compensate for...
Chronic Kidney Disease II: Clinical Manifestations01:24

Chronic Kidney Disease II: Clinical Manifestations

Chronic Kidney Disease (CKD) progressively impairs multiple body systems due to the accumulation of uremic toxins, which disrupt cellular functions across various organs.Neurologic symptomsNeurologic symptoms often arise early in CKD, as uremic toxin buildup drives changes in cognitive and motor functions. Patients frequently experience fatigue, headache, confusion, difficulty concentrating, and, in severe cases, seizures. Peripheral neuropathy commonly manifests as burning sensations in the...
Heart Failure Drugs: Diuretics01:22

Heart Failure Drugs: Diuretics

Heart failure and kidney perfusion are interconnected in a complex way. Reduced renal perfusion and venous congestion are two significant factors that contribute to renal dysfunction in heart failure. The kidneys, primarily responsible for fluid balance in the body, are adversely affected due to compromised cardiac output and increased venous pressure. In response to reduced renal perfusion, the kidneys activate neurohumoral mechanisms to restore balance. However, these mechanisms can be...
Cardiomyopathy V: Interprofessional Care01:29

Cardiomyopathy V: Interprofessional Care

Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...